ClinVar Miner

Submissions for variant NM_001134407.3(GRIN2A):c.547T>A (p.Phe183Ile)

gnomAD frequency: 0.00004  dbSNP: rs587780353
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 10
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000117178 SCV000151342 likely benign not specified 2013-05-14 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000711852 SCV000842258 uncertain significance not provided 2017-09-18 criteria provided, single submitter clinical testing
Ambry Genetics RCV002313887 SCV000847626 uncertain significance Inborn genetic diseases 2017-10-27 criteria provided, single submitter clinical testing The p.F183I variant (also known as c.547T>A), located in coding exon 2 of the GRIN2A gene, results from a T to A substitution at nucleotide position 547. The phenylalanine at codon 183 is replaced by isoleucine, an amino acid with highly similar properties. In one study, this variant was detected in an individual with benign epilepsy with centrotemporal spikes (rolandic epilepsy). The variant was not present in the patient's asymptomatic father (mother's variant status unknown) (Lemke JR et al. Nat. Genet., 2013 Sep;45:1067-72). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.
Invitae RCV000989528 SCV001011206 likely benign Landau-Kleffner syndrome 2024-01-28 criteria provided, single submitter clinical testing
Mendelics RCV000989528 SCV001139948 benign Landau-Kleffner syndrome 2019-05-28 criteria provided, single submitter clinical testing
GeneDx RCV000711852 SCV001815411 likely benign not provided 2023-04-28 criteria provided, single submitter clinical testing See Variant Classification Assertion Criteria.
Revvity Omics, Revvity RCV000989528 SCV003815185 uncertain significance Landau-Kleffner syndrome 2020-12-10 criteria provided, single submitter clinical testing
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden RCV000711852 SCV004026266 uncertain significance not provided 2023-05-10 criteria provided, single submitter clinical testing PP3, PP4, PM2_SUP
CeGaT Center for Human Genetics Tuebingen RCV000711852 SCV004141111 uncertain significance not provided 2023-01-01 criteria provided, single submitter clinical testing
Bioinformatics Core, Luxembourg Center for Systems Biomedicine RCV000656052 SCV000588328 pathogenic Childhood epilepsy with centrotemporal spikes 2017-01-01 no assertion criteria provided case-control CAADphred>15

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.